BDSX
Biodesix Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
0.00%
BDSX weight · VTI
Biodesix has 4 disclosed suppliers and 1 disclosed customer in SEC filings.
—
Biodesix Inc
22.97
SentenceFor the years ended December 31, 2025 and 2024, Medicare reimbursed 32% and 39%, respectively, of our total revenue to us.
basisBDSX FY2025 revenue $88M
BDSX 10-Kaccession 0001193125-26-076547
SentenceFreenome is also the sole source supplier for our Nodify CDT tests but there are known secondary suppliers for these materials.
BDSX 10-Kaccession 0001193125-26-076547
SentenceOn April 22, 2024, the Company obtained consent from Perceptive and prepaid the July 1, 2024 contingent consideration milestone payment of $8.4 million to Integrated Diagnostics (Indi).
BDSX 10-Kaccession 0001193125-26-076547
SentenceIncluded under the PCA was (a) an APA whereby we acquired all of the United States assets associated with the De Soto, Kansas clinical laboratory, as well as the trademarks and patent application associated with the test; (b) an intellectual property license granting us the rights necessary under Oncimmune's background intellectual property rights to perform the Nodify CDT test; (c) a supply agreement for supplying us with the necessary materials and reagents needed to run the Nodify CDT test; and (d) a development agreement where Oncimmune agrees to assist us in further developing the Nodify CDT test.
BDSX 10-Kaccession 0001193125-26-076547
Expected move
No implied move.